Stocks
Bluejay Diagnostics, Inc.BJDX
NASDAQHealthcareDiagnostics$0.69
Price as of · delayed, not real-time
A developer of rapid in vitro diagnostic tests, this small-cap healthcare firm focuses on point-of-care testing for critical care settings. Its lead product candidate targets sepsis and other acute conditions, and investors track it for its potential in a high-demand diagnostics niche.
52W Range: $0.67-$10.52
Congressional Interest in Bluejay Diagnostics, Inc. (BJDX)
No congressional trades have been disclosed for Bluejay Diagnostics, Inc. (BJDX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BJDX?
No congressional trades found for this stock.